Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6274424 | 0.84 | ALDH1A1 (0.52) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL9780681 | 0.83 | LMNA (0.50) | ALDH1A1MAPK1L3MBTL1TDP1CYP1A2 | |
| SCHEMBL24012258 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL11302396 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL11407232 | 0.82 | LTA4H (0.47) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL28745388 | 0.81 | SLC1A1 (0.45) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL15309173 | 0.80 | ALDH1A1 (0.47) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL30381497 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL28748317 | 0.80 | ALDH1A1 (0.47) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL27811410 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732599-B2 | from neopterin and/or 6-substituted pterins with improved yield and high stereoselectivity; reduction catalysts | BIOMARIN PHARMACEUTICAL INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-20080051578-A1 | SUBSTITUTED BIARYLS, PROCESS FOR THEIR MANUFACTURE AND USE THEREOF AS MEDICAMENTS | DAHMANN GEORG | 2008-02-28 | — | — | US | disclosed |
| US-20070244322-A1 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin | MERCK EPROVA AG (CH) | 2007-10-18 | — | — | US | disclosed |
| EP-1776364-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BioMarin Pharmaceutical Inc. (US) | 2007-04-25 | — | — | EP | disclosed |
| WO-2005049614-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BIOMARIN PHARMACEUTICAL INC. (US) | 2005-06-02 | — | — | WO | disclosed |
| EP-0385336-B1 | PROCESSES FOR THE PREPARATION OF PTERIN DERIVATIVES | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1993-06-02 | — | — | EP | disclosed |
| US-5043446-A | Subjecting ribose to acetalization, Grignard, oxidative cleavage, hydrazoning, condensing with pyridine to 1-biopterin | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1991-08-27 | — | — | US | disclosed |
| US-5003099-A | Method for the production of aminocyanoacetamide | LONZA LTD. (CH) | 1991-03-26 | — | — | US | disclosed |
| EP-0385336-A2 | Processes for the preparation of pterin derivatives | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| CN-86102450-A | The method for preparing heterogeneous ring compound | — | 1987-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051578-A1 | SUBSTITUTED BIARYLS, PROCESS FOR THEIR MANUFACTURE AND USE THEREOF AS MEDICAMENTS | CYP11B2, CYP3A43, CYP11B1 | ALDH1A1 517/4885KMT2A 2377/4885MAPK1 4379/4885 |
| US-20070244322-A1 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin | SPR, DHPS, BLVRB | ALDH1A1 3894/4885KMT2A 4011/4885MAPK1 3935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.